- Home
- ACHC vs SDGR Comparison
ACHC vs SDGR Comparison
Compare ACHC & SDGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACHC
- SDGR
- Stock Information
- Founded
- ACHC 2005
- SDGR 1990
- Country
- ACHC United States
- SDGR United States
- Employees
- ACHC N/A
- SDGR N/A
- Industry
- ACHC Medical Specialities
- SDGR Biotechnology: Pharmaceutical Preparations
- Sector
- ACHC Health Care
- SDGR Health Care
- Exchange
- ACHC Nasdaq
- SDGR Nasdaq
- Market Cap
- ACHC 2.0B
- SDGR 1.7B
- IPO Year
- ACHC N/A
- SDGR 2020
- Fundamental
- Price
- ACHC $21.56
- SDGR $20.46
- Analyst Decision
- ACHC Buy
- SDGR Buy
- Analyst Count
- ACHC 9
- SDGR 5
- Target Price
- ACHC $47.94
- SDGR $32.80
- AVG Volume (30 Days)
- ACHC 1.7M
- SDGR 1.2M
- Earning Date
- ACHC 07-30-2025
- SDGR 07-30-2025
- Dividend Yield
- ACHC N/A
- SDGR N/A
- EPS Growth
- ACHC N/A
- SDGR N/A
- EPS
- ACHC 2.04
- SDGR N/A
- Revenue
- ACHC $3,156,417,000.00
- SDGR $230,492,000.00
- Revenue This Year
- ACHC $7.83
- SDGR $24.44
- Revenue Next Year
- ACHC $8.56
- SDGR $22.17
- P/E Ratio
- ACHC $10.53
- SDGR N/A
- Revenue Growth
- ACHC 5.48
- SDGR 22.29
- 52 Week Low
- ACHC $20.36
- SDGR $16.60
- 52 Week High
- ACHC $82.41
- SDGR $28.47
- Technical
- Relative Strength Index (RSI)
- ACHC 41.33
- SDGR 37.57
- Support Level
- ACHC $20.47
- SDGR $20.90
- Resistance Level
- ACHC $23.18
- SDGR $21.62
- Average True Range (ATR)
- ACHC 0.98
- SDGR 1.37
- MACD
- ACHC -0.03
- SDGR -0.35
- Stochastic Oscillator
- ACHC 38.93
- SDGR 4.46
About ACHC Acadia Healthcare Company Inc.
Acadia Healthcare Co Inc acquires and develops behavioral healthcare facilities. Acute inpatient psychiatric facilities and specialty treatment facilities contribute the vast majority of Acadia's revenue in the United States. The company's revenue is derived from services rendered to patients for inpatient psychiatric and substance abuse care, outpatient psychiatric care, and adolescent residential treatment.
About SDGR Schrodinger Inc.
Schrodinger Inc is a healthcare-based software company. Its operating segments are Software and Drug discovery. Through the Software segment, the company is focused on selling software to transform drug discovery across the life sciences industry and customers in materials science industries. In the Drug discovery segment, it is engaged in generating revenue from a portfolio of preclinical and clinical programs, internally and through collaborations. It generates revenue from the sales of software solutions and from research funding and milestone payments from its drug discovery collaborations.